These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31191506)

  • 1. Seneca Valley Virus 2C and 3C
    Liu T; Li X; Wu M; Qin L; Chen H; Qian P
    Front Microbiol; 2019; 10():1202. PubMed ID: 31191506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seneca Valley Virus 3C
    Xue Q; Liu H; Zhu Z; Xue Z; Liu X; Zheng H
    Pathogens; 2020 Jun; 9(6):. PubMed ID: 32512928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seneca Valley virus 2C and 3C inhibit type I interferon production by inducing the degradation of RIG-I.
    Wen W; Yin M; Zhang H; Liu T; Chen H; Qian P; Hu J; Li X
    Virology; 2019 Sep; 535():122-129. PubMed ID: 31299488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.
    Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seneca Valley virus circumvents Gasdermin A-mediated inflammation by targeting the pore-formation domain for cleavage.
    Yin H; Zhao Z; Yan Y; Yuan Y; Qu W; Wang H; Zhu C; Li P; Li X
    mBio; 2024 Oct; 15(10):e0168024. PubMed ID: 39207099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seneca Valley Virus 3C Protease Induces Pyroptosis by Directly Cleaving Porcine Gasdermin D.
    Wen W; Li X; Wang H; Zhao Q; Yin M; Liu W; Chen H; Qian P
    J Immunol; 2021 Jul; 207(1):189-199. PubMed ID: 34183365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seneca Valley Virus Induces DHX30 Cleavage to Antagonize Its Antiviral Effects.
    Wen W; Zheng Z; Wang H; Zhao Q; Yin M; Chen H; Li X; Qian P
    J Virol; 2022 Sep; 96(17):e0112122. PubMed ID: 36000840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seneca Valley Virus 3C
    Song J; Quan R; Wang D; Liu J
    Microbiol Spectr; 2022 Apr; 10(2):e0030422. PubMed ID: 35357201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seneca Valley Virus 3C
    Xue Q; Liu H; Zhu Z; Yang F; Ma L; Cai X; Xue Q; Zheng H
    Virology; 2018 May; 518():1-7. PubMed ID: 29427864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seneca valley virus 3C protease blocks EphA2-Mediated mTOR activation to facilitate viral replication.
    Shi Y; Wu Z; Zeng P; Song J; Guo J; Yang X; Zhou J; Liu J; Hou L
    Microb Pathog; 2024 Jun; 191():106673. PubMed ID: 38705218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seneca Valley virus 3C
    Song J; Wang D; Quan R; Liu J
    Virulence; 2021 Dec; 12(1):3125-3136. PubMed ID: 34923914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senecavirus A 3C Protease Mediates Host Cell Apoptosis Late in Infection.
    Fernandes MHV; Maggioli MF; Otta J; Joshi LR; Lawson S; Diel DG
    Front Immunol; 2019; 10():363. PubMed ID: 30918505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic Seneca Valley Virus: past perspectives and future directions.
    Burke MJ
    Oncolytic Virother; 2016; 5():81-9. PubMed ID: 27660749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seneca Valley Virus 3C protease negatively regulates the type I interferon pathway by acting as a viral deubiquitinase.
    Xue Q; Liu H; Zhu Z; Yang F; Xue Q; Cai X; Liu X; Zheng H
    Antiviral Res; 2018 Dec; 160():183-189. PubMed ID: 30408499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seneca Valley Virus 3C
    Song J; Quan R; Wang D; Liu J
    Front Microbiol; 2022; 13():945443. PubMed ID: 35875542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seneca Valley virus enters cells through multiple pathways and traffics intracellularly via the endolysosomal pathway.
    Liu W; Shang X; Wen W; Ren X; Qin L; Li X; Qian P
    J Gen Virol; 2023 Mar; 104(3):. PubMed ID: 36947577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug Therapy.
    Miles LA; Brennen WN; Rudin CM; Poirier JT
    PLoS One; 2015; 10(6):e0129103. PubMed ID: 26069962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seneca Valley virus 3C
    Zhang XY; Li YY; Huang HX; Zhao CC; Lei XX; Zhao BP; Lu JY; Lan T; Sun WC
    Front Microbiol; 2023; 14():1235620. PubMed ID: 37869659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of a Seneca Valley virus thermostable mutant.
    Jayawardena N; McCarthy C; Wang I; Waqqar S; Burga LN; Strauss M; Bostina M
    Virology; 2022 Oct; 575():74-82. PubMed ID: 36084546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallization and preliminary X-ray diffraction studies of Seneca Valley virus-001, a new member of the Picornaviridae family.
    Venkataraman S; Reddy SP; Loo J; Idamakanti N; Hallenbeck PL; Reddy VS
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Apr; 64(Pt 4):293-6. PubMed ID: 18391430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.